Showing 1 - 10 of 10,000
Int’l Fact-Checking Day 2026: Collective Action Against AI-Era Disinformation
Published on 24/04/2026
» The International Fact-Checking Network (IFCN) has designated April 2 each year as International Fact-Checking Day, following April Fools' Day, to remind the public of the importance of verifying facts before believing or sharing content, to prevent the spread of misinformation and disinformation.
Sasin and SCGC Kick Off Global Competition for Impact-Driven Startups
Published on 24/04/2026
» Sasin School of Management, in collaboration with SCG Chemicals (SCGC), a leading innovator in the polymer business and integrated solutions for sustainability, has launched the Bangkok Business Challenge 2026 Powered by SCGC under the theme “Growing Impactful Ventures: Building Solutions for Tomorrow’s World.” The global student startup competition brings together university teams to present and pitch sustainable, innovation-driven business solutions to a distinguished panel of accomplished entrepreneurs, investors, and industry leaders.
The 1 Day 2026 returns: A nationwide shopping phenomenon, greater than ever
Published on 24/04/2026
» The 1, Thailand’s leading digital lifestyle and loyalty platform under Central Group, reunites with Central The 1 Credit Card to launch “The 1 Day 2026”—transforming from a limited campaign into a month-long nationwide phenomenon. This year, the event delivers the “Best Value of the Year” across all four regions of Thailand, bringing unparalleled benefits to members nationwide.
Your horoscope for April 24-30
Guru, Chaiyospol Hemwijit, Published on 24/04/2026
» Your spot-on horoscope for work, money and relationship from Guru by the Bangkok Post's famously accurate fortune teller. Let's see how you will fare this week and beyond.
Omnicom Media Positions Brands for Growth in Thailand’s Rapidly Transforming Media Landscape
Published on 24/04/2026
» Bangkok, Thailand [April 21, 2026] — Thailand’s media industry is undergoing a profound structural transformation, shaped by artificial intelligence, accelerating fragmentation, and rapidly evolving consumer behaviours. In response to this shift, Omnicom Media is strengthening its position as the country’s most powerful and future-ready media network— helping brands navigate complexity and unlock growth.
Singapore emerging as neutral ground as AI firms navigate Sino-US rivalry
Published on 24/04/2026
» SINGAPORE - Singapore is transforming from East-West gateway to neutral ground for the AI sector, with Chinese startups hoping to operate beyond government reach while US firms seek foreign talent without the headache of stricter visa regulations.
Agential Cannabis 2026 Takes Shape as APAC’s B2B Medicinal Cannabis Marketplace
Published on 24/04/2026
» Agential Cannabis 2026 will take place on 23–24 September 2026 at Bangkok International Trade & Exhibition Centre (BITEC), Bangkok, Thailand. Built for the growers, licensed producers, buyers, and manufacturers working across APAC’s medicinal cannabis industry, the two-day event pairs an international conference with a deliberately focused B2B expo covering the full value chain — from genetics and cultivation through to extraction, quality, and market access.
Soviet architecture vanishes as Central Asia drifts from Moscow
AFP, Published on 24/04/2026
» DUSHANBE (TAJIKISTAN) - On the facade of an apartment block in Tajikistan's capital Dushanbe, a giant mosaic depicting cosmonauts and engineers celebrates the scientific triumphs of the Soviet Union.
Siam Cement set to close Vietnam plant next month
Business, Nareerat Wiriyapong, Published on 24/04/2026
» Concerns over a raw material shortage in Thailand's manufacturing sector are growing after Siam Cement (SCC) announced a temporary suspension of its Vietnam petrochemical complex because the prolonged closure of the Strait of Hormuz is causing constraints in feedstock procurement.
US eases access to marijuana for medical use
AFP, Published on 24/04/2026
» WASHINGTON - The US government on Thursday made it easier for Americans to use cannabis for medical reasons by reclassifying the drug and enabling more research into its safety and efficacy.